FDMT
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- 4DMT advances 4D-150 into Phase 3 for a second large-market retinal indication and initiates the 4SIGHT trial in diabetic macular edemaSep 28, 2026
- 4DMT reports positive two-year Phase 2b PRISM trial results in a broad wet AMD populationJul 19, 2026
- 4DMT completed enrollment in the global Phase 3 4FRONT-2 trial of 4D-150 for wet AMDJun 29, 2026
- 4DMT completed enrollment in the Phase 3 4FRONT-1 trial evaluating 4D-150 for wet age-related macular degenerationFeb 9, 2026
- 4DMT announces positive interim data from 4D-710 AEROW Phase 1 trial in cystic fibrosisDec 17, 2025